{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:59:12Z","timestamp":1790765952605,"version":"4.1.0"},"reference-count":59,"publisher":"Oxford University Press (OUP)","issue":"10","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF24OC0091975"],"award-info":[{"award-number":["NNF24OC0091975"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Fracture risk increases along the progression of chronic kidney disease (CKD) to become several-fold higher in patients with CKD G4-5D as compared to the kidney-healthy background population matched for age and sex. In 2023, Kidney Disease Improving Global Outcomes (KDIGO) introduced the term CKD-associated osteoporosis to acknowledge and emphasize the overlap in diagnostic workup and therapeutic choices when treating bone fragility in CKD versus other conditions of osteoporosis, while maintaining the need to individualize the treatment plan with knowledge of CKD. Although evidence-based practice guidelines promote management strategies that are widely accepted in postmenopausal women and elderly men, there is a clear need to perform randomized controlled trials to confirm or disprove the benefits of therapy in the setting of advanced CKD. Lifestyle modification, as a \u2018low risk\/potentially high return\u2019 intervention, should be considered in all patients. Current evidence furthermore supports a sequential approach to treatment, where mineral metabolism should be optimized, including parathyroid hormone targeting therapy, before initiating bone targeting drugs. We review the current standards of treatment and discuss novel developments in the pathophysiology, diagnosis, outcome prediction and management of CKD-associated osteoporosis and propose a pragmatic treatment algorithm, pending more definite evidence from appropriately designed and powered clinical trials.<\/jats:p>","DOI":"10.1093\/ndt\/gfag124","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T11:59:04Z","timestamp":1786017544000},"page":"1795-1804","source":"Crossref","is-referenced-by-count":0,"title":["CKD-associated osteoporosis in patients with CKD G4-5D: a pragmatic treatment approach"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-4321","authenticated-orcid":false,"given":"Pieter","family":"Evenepoel","sequence":"first","affiliation":[{"name":"Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven , Leuven ,","place":["Belgium"]},{"name":"Department of Nephrology, University Hospitals Leuven , Leuven ,","place":["Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0881-2615","authenticated-orcid":false,"given":"Hanne Skou","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus University , Aarhus ,","place":["Denmark"]},{"name":"Department of Clinical Medicine, Aalborg University , Aalborg ,","place":["Denmark"]},{"name":"Department of Nephrology, Aalborg University , Aalborg ,","place":["Denmark"]},{"name":"Department of Renal Medicine, Aarhus University Hospital , Aarhus ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"2026093006070304300_bib1","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1093\/ndt\/gfw073","article-title":"Risk of fracture in adults on renal replacement therapy: a Danish national cohort study","volume":"31","author":"Hansen","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070304300_bib2","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1002\/jbmr.4141","article-title":"Incidence of fractures before and after dialysis initiation","volume":"35","author":"Iseri","year":"2020","journal-title":"J Bone Miner Res"},{"key":"2026093006070304300_bib3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1007\/s00223-020-00786-0","article-title":"Traditional and non-traditional risk factors for osteoporosis in CKD","volume":"108","author":"J\u00f8rgensen","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"2026093006070304300_bib4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.kint.2024.11.013","article-title":"Chronic kidney disease-mineral and bone disorder: conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference","volume":"107","author":"Ketteler","year":"2025","journal-title":"Kidney Int"},{"key":"2026093006070304300_bib5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4\u2013G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol DialTransplant"},{"key":"2026093006070304300_bib6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00198-022-06598-2","article-title":"Prevalence of low bone mineral density (T-score &lt;\/=\u20132.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis","volume":"34","author":"Duarte","year":"2023","journal-title":"Osteoporos Int"},{"key":"2026093006070304300_bib7","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfag038","article-title":"Therapeutic opportunities for CKD-associated osteoporosis in adults with kidney failure imply screening","author":"Engelen","year":"2026","journal-title":"Nephrol Dial Transplan t"},{"key":"2026093006070304300_bib8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11657-025-01570-z","article-title":"Real-world data from a national survey on management of CKD-associated osteoporosis among Italian nephrologists","volume":"20","author":"Fusaro","year":"2025","journal-title":"Arch Osteoporos"},{"key":"2026093006070304300_bib9","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.xkme.2021.07.005","article-title":"Prescription patterns of osteoporosis medications in patients with advanced CKD: a retrospective cohort study","volume":"3","author":"Portales-Castillo","year":"2021","journal-title":"Kidney Med"},{"key":"2026093006070304300_bib10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/ndt\/gfad185","article-title":"Recommended calcium intake in adults and children with chronic kidney disease-a European consensus statement","volume":"39","author":"Evenepoel","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070304300_bib11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/ndt\/gfae293","article-title":"The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation\u2014a European consensus statement","volume":"40","author":"J\u00f8rgensen","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070304300_bib12","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1681\/ASN.0000000000000085","article-title":"Comprehensive associations between acidosis and the skeleton in patients with kidney disease","volume":"34:","author":"Levy","year":"2023","journal-title":"J Am Soc Nephrol"},{"key":"2026093006070304300_bib13","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1002\/jbmr.309","article-title":"Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients","volume":"26","author":"Malluche","year":"2011","journal-title":"J Bone Mineral Res"},{"key":"2026093006070304300_bib14","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.bonr.2018.03.005","article-title":"Bone histomorphometry in the evaluation of osteomalacia","volume":"8","author":"Bhan","year":"2018","journal-title":"Bone Rep"},{"key":"2026093006070304300_bib15","first-page":"e20240023","article-title":"Bone aluminum accumulation in the current era","volume":"46","author":"Oliveira","year":"2024","journal-title":"J Bras Nefrol"},{"key":"2026093006070304300_bib16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00774-013-0480-7","article-title":"Osteomalacia induced by vitamin D deficiency in hemodialysis patients: the crucial role of vitamin D correction","volume":"32","author":"Mac-Way","year":"2014","journal-title":"J Bone Miner Metab"},{"key":"2026093006070304300_bib17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/ndt\/gfae197","article-title":"Multidisciplinary team approach for CKD-associated osteoporosis","volume":"40:","author":"Hansen","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070304300_bib18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/ndt\/gfz163","article-title":"What does a PTH of 300 pg\/mL actually mean?","volume":"36","author":"Cavalier","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070304300_bib19","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"2026093006070304300_bib20","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","article-title":"Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO), International Osteoporosis Foundation (IOF), and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos Int"},{"key":"2026093006070304300_bib21","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1053\/j.ajkd.2021.07.027","article-title":"Diagnostic accuracy of noninvasive bone turnover markers in renal osteodystrophy","volume":"79","author":"J\u00f8rgensen","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"2026093006070304300_bib22","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfag033","article-title":"Bone turnover markers in the management of CKD-associated osteoporosis\u2014a European consensus","author":"Haarhaus","year":"2026","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070304300_bib23","first-page":"1","article-title":"KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"7","author":"Kidney Disease: Improving Global Outcomes, C.K.D.M.B.D.U.W.G.","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"2026093006070304300_bib24","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.1016\/j.ekir.2024.07.008","article-title":"Lower parathyroid hormone levels are associated with reduced fracture risk in japanese patients on hemodialysis","volume":"9","author":"Komaba","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2026093006070304300_bib25","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.2215\/CJN.0000000000000254","article-title":"Changes in bone quality after treatment with etelcalcetide","volume":"18","author":"Khairallah","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026093006070304300_bib26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00774-024-01500-y","article-title":"Effectiveness of calcimimetics on fractures in dialysis patients with secondary hyperparathyroidism: meta-analysis of randomized trials","volume":"42","author":"Wakamatsu","year":"2024","journal-title":"J Bone Miner Metab"},{"key":"2026093006070304300_bib27","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1093\/jbmr\/zjae119","article-title":"Goal-directed osteoporosis treatment: ASBMR\/BHOF task force position statement 2024","volume":"39","author":"Cosman","year":"2024","journal-title":"J Bone Miner Res"},{"key":"2026093006070304300_bib28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J Bone Miner Res"},{"key":"2026093006070304300_bib29","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J Bone Miner Res"},{"key":"2026093006070304300_bib30","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/jbmr\/zjae193","article-title":"Risk factors for osteonecrosis of the jaw in patients with chronic kidney disease: a nested case-control study","volume":"40","author":"Iseri","year":"2025","journal-title":"J Bone Miner Res"},{"key":"2026093006070304300_bib31","doi-asserted-by":"publisher","first-page":"e20831","DOI":"10.1097\/MD.0000000000020831","article-title":"Effect of different hydration doses on renal function in patients with primary osteoporosis treated with zoledronic acid: a hospital-based retrospective cohort study","volume":"99","author":"Dai","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2026093006070304300_bib32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s00198-021-06160-6","article-title":"Evaluation of estimated glomerular function (eGFR) versus creatinine clearance (CrCl) to predict acute kidney injury when using zoledronate for the treatment of osteoporosis","volume":"33","author":"Schini","year":"2022","journal-title":"Osteoporos Int"},{"key":"2026093006070304300_bib33","doi-asserted-by":"publisher","DOI":"10.1093\/jbmr\/zjaf195","article-title":"Safety of low dose inpatient zoledronic acid in acute hip fracture patients with advanced chronic kidney disease","author":"Sun","year":"2026","journal-title":"J Bone Miner Re s"},{"key":"2026093006070304300_bib34","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1002\/jbmr.4235","article-title":"Safety of oral bisphosphonates in moderate-to-severe chronic kidney disease: a binational cohort analysis","volume":"36","author":"Robinson","year":"2021","journal-title":"J Bone Mineral Res"},{"key":"2026093006070304300_bib35","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.kint.2021.04.043","article-title":"Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment","volume":"100","author":"Haarhaus","year":"2021","journal-title":"Kidney Int"},{"key":"2026093006070304300_bib36","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1210\/clinem\/dgac142","article-title":"Parathyroidectomy vs cinacalcet among patients undergoing hemodialysis","volume":"107","author":"Komaba","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026093006070304300_bib37","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ekir.2024.01.002","article-title":"Alkaline phosphatase and parathyroid hormone levels: international variation and associations with clinical outcomes in the DOPPS","volume":"9","author":"Yamamoto","year":"2024","journal-title":"Kidney Int Rep"},{"key":"2026093006070304300_bib38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1359\/JBMR.051018","article-title":"Pretreatment levels of bone turnover and the antifracture efficacy of alendronate: the fracture intervention trial","volume":"21","author":"Bauer","year":"2006","journal-title":"J Bone Miner Res"},{"key":"2026093006070304300_bib39","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1001\/jama.2023.28239","article-title":"Severe hypocalcemia with denosumab among older female dialysis-dependent patients","volume":"331","author":"Bird","year":"2024","journal-title":"JAMA"},{"key":"2026093006070304300_bib40","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/jbmr.4804","article-title":"Hypocalcemia risk of denosumab across the spectrum of kidney disease: a population-based cohort study","volume":"38","author":"Cowan","year":"2023","journal-title":"J Bone Miner Res"},{"key":"2026093006070304300_bib41","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1093\/ndt\/gfaa359","article-title":"Hypocalcemia and bone mineral changes in hemodialysis patients with low bone mass treated with denosumab: a 2-year observational study","volume":"36:","author":"Hiramatsu","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2026093006070304300_bib42","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1038\/s41598-020-59143-8","article-title":"Denosumab for dialysis patients with osteoporosis: a cohort study","volume":"10","author":"Kunizawa","year":"2020","journal-title":"Sci Rep"},{"key":"2026093006070304300_bib43","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s11657-023-01341-8","article-title":"Reducing the risk of denosumab-induced hypocalcemia in patients with advanced chronic kidney disease: a quality improvement initiative","volume":"18","author":"Kanagalingam","year":"2023","journal-title":"Arch Osteoporos"},{"key":"2026093006070304300_bib44","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1007\/s00774-022-01331-9","article-title":"The relationship between chronic kidney disease and denosumab-induced hypocalcemia in high-age osteoporotic patients","volume":"40","author":"Horikawa","year":"2022","journal-title":"J Bone Miner Metab"},{"key":"2026093006070304300_bib45","doi-asserted-by":"publisher","first-page":"117874","DOI":"10.1016\/j.bone.2026.117874","article-title":"Denosumab-induced hypocalcemia: detection of drug-drug interactions using disproportionality analysis in VigiBase(R)","author":"Batteux","year":"2026","journal-title":"Bone"},{"key":"2026093006070304300_bib46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int"},{"key":"2026093006070304300_bib47","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s00198-015-3377-6","article-title":"Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study","volume":"27","author":"Sumida","year":"2016","journal-title":"Osteoporos Int"},{"key":"2026093006070304300_bib48","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/1744-9987.12867","article-title":"Impact of weekly teriparatide on the bone and mineral metabolism in hemodialysis patients with relatively low serum parathyroid hormone: a pilot study","volume":"24","author":"Yamamoto","year":"2020","journal-title":"Ther Apher Dial"},{"key":"2026093006070304300_bib49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.5414\/CN110993","article-title":"Treatment of bone loss in CKD5D: better survival in patients with non-high bone turnover","volume":"98","author":"Malluche","year":"2022","journal-title":"Clin Nephrol"},{"key":"2026093006070304300_bib50","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1080\/03007995.2019.1656955","article-title":"Abaloparatide in patients with mild or moderate renal impairment: results from the ACTIVE phase 3 trial","volume":"35","author":"Bilezikian","year":"2019","journal-title":"Curr Med Res Opin"},{"key":"2026093006070304300_bib51","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/jbmr.4563","article-title":"Efficacy and safety of romosozumab among postmenopausal women with osteoporosis and mild-to-moderate chronic kidney disease","volume":"37","author":"Miller","year":"2022","journal-title":"J BoneMiner Res"},{"key":"2026093006070304300_bib52","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1007\/s00774-021-01253-y","article-title":"Efficacy of romosozumab in patients with osteoporosis on maintenance hemodialysis in Japan; an observational study","volume":"39","author":"Sato","year":"2021","journal-title":"J Bone Miner Metab"},{"key":"2026093006070304300_bib53","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s00223-022-01031-6","article-title":"One-year romosozumab treatment followed by one-year denosumab treatment for osteoporosis in patients on hemodialysis: an observational study","volume":"112","author":"Saito","year":"2023","journal-title":"Calcif Tissue Int"},{"key":"2026093006070304300_bib54","doi-asserted-by":"publisher","first-page":"ziaf096","DOI":"10.1093\/jbmrpl\/ziaf096","article-title":"Comparative analysis of romosozumab and denosumab treatment in hemodialysis patients with osteoporosis: a 12-mo observational study","volume":"9","author":"Teraguchi","year":"2025","journal-title":"JBMR Plus"},{"key":"2026093006070304300_bib55","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11914-020-00652-w","article-title":"Romosozumab: a review of efficacy, safety, and cardiovascular risk","volume":"19","author":"Fixen","year":"2021","journal-title":"Curr Osteoporos Rep"},{"key":"2026093006070304300_bib56","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/jbmr.4503","article-title":"Sclerostin protects against vascular calcification development in mice","volume":"37","author":"De\u00a0Mar\u00e9","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2026093006070304300_bib57","doi-asserted-by":"publisher","first-page":"3221","DOI":"10.1210\/jc.2013-1521","article-title":"Sclerostin: another vascular calcification inhibitor?","volume":"98","author":"Claes","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026093006070304300_bib58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11914-025-00909-2","article-title":"Sequential and Long-term Therapy for Osteoporosis","volume":"23","author":"McClung","year":"2025","journal-title":"Curr Osteoporos Rep"},{"key":"2026093006070304300_bib59","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41574-023-00866-9","article-title":"Long-term and sequential treatment for osteoporosis","volume":"19","author":"Foessl","year":"2023","journal-title":"Nat Rev Endocrinol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag124\/70531132\/gfag124.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/10\/1795\/70531132\/gfag124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/41\/10\/1795\/70531132\/gfag124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:07:11Z","timestamp":1790762831000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/41\/10\/1795\/8754120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,8,7]]},"published-print":{"date-parts":[[2026,9,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag124","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,8,7]]}}}